|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Babraham Research Campus,Moneta Building,Cambridge,GB
|
|
STORM Therapeutics Limited | 2,439 followers on LinkedIn. Harnessing the power of RNA epigenetics | STORM Therapeutics (www.stormtherapeutics.com) is a spin out company translating the groundbreaking work in RNA epigenetics of Prof Tony Kouzarides and Prof Eric Miska of the Gurdon Institute, University of Cambridge into the discovery of first in class drugs in oncology and other diseases
Several large families of RNA-modifying enzymes have been identified that impact key biological processes by changing the activity of RNA through catalysing epigenetic RNA modifications. Advances in the understanding of RNA modification and its role in the development of cancer offer the prospect of exploring novel therapeutic targets and potential discovery and development of first-in-class products. STORM is working at the forefront of this new field.
|
STORM Therapeutics Limited Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used STORM Therapeutics Limited email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact STORM Therapeutics Limited customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.